PAI and TPA gene polymorphisms in multiple sclerosis

Abstract

Multiple sclerosis (MS) is an immune-mediated chronic inflammatory demyelinating disease of the central nervous system. It manifests as acute focal inflammatory demyelination and axonal loss with limited remyelination and results in the chronic multifocal sclerotic plaques. Previously published data showed impaired fibrinolysis in MS. Tissue plasminogen activator t-PA is a serine protease that catalyses the activation of plasmin, which mediates the effects of fibrinolytic system. Alu insertion/deletion (I/D) genetic polymorphism in TPA gene in MS patients has not been analysed previously. The major inhibitor of t-PA is plasminogen activator inhibitor-1 (PAI-1). Its gene expression is modulated by functional genetic polymorphism in the promoter (4G/5G). In the present study, an association of two genetic polymorphisms with MS, its progression and subtype were analysed. TPA DD/PAI-1 4G4G genotype combination has reached a borderline significance for reduced risk for MS (OR = 0.543, 95% CI 0.301—0.978, P = 0.04), suggesting a gene—gene interaction. The explanation for this interaction may be a complex interplay between these two pleiotropic proteins within the brain tissue and in plasma. Multiple Sclerosis 2008; 14: 243—247. http://msj.sagepub.com

Keywords

gene polymorphism multiple sclerosis PAI 4G/5G TPA Alu I/D susceptibility gene

Get full access to this article

View all access options for this article.

References

Compston A. , Coles A. Multiple sclerosis . The Lancet 2002; 359(6): 1221—31.

Martinez Doncel A , Rubio A. , Arroyo R. , de las Heras V. , Martin C. , Fernandez-Arquero M. , et al. Interleukin-10 polymorphisms in Spanish multiple sclerosis patients . J Neuroimmunol 2002; 131(1—2): 168—72.

Gveric D. , Hanemaaijer R. , Newcombe J. , van Lent NA , Sier CF , Cuzner ML Plasminogen activators in multiple sclerosis lesions: implications for the inflammatory response and axonal damage . Brain 2001; 124: 1978—88.

Gveric D. , Herrera B. , Petzold A. , Lawrence DA , Cuzner ML Impaired fibrinolysis in multiple sclerosis: a role for tissue plasminogen activator inhibitors . Brain 2003; 126(Pt 7): 1590—8.

Gveric D. , Herrera BM , Cuzner ML tPA receptors and the fibrinolytic response in multiple sclerosis lesions . Am J Pathol 2005; 166(4): 1143—51.

Teesalu T. , Hinkkanen AE , Vaheri A. Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice . Am J Pathol 2001; 159(6): 2227—37.

Eriksson P. , Kallin B. , van `t Hooft FM , Bavenholm P. , Hamsten A. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction . Proc Natl Acad Sci USA 1995; 92(6): 1851—5.

Luomala M. , Elovaara I. , Ukkonen M. , Koivula T. , Lehtimaki T. Plasminogen activator inhibitor 1 gene and risk of MS in women . Neurology 2000; 54(9): 1862—4.

Poser CM , Paty DW , Scheinberg L. , McDonald WI , Davies FA , Ebers GC , et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols . Ann Neurol 1983; 13: 227—31.

10.

Kurtzke JF Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) . Neurology 1983; 33(11): 1444—52.

11.

Margaglione M. , Grandone E. , Cappucci G. , Colaizzo D. , Giuliani N. , Vecchione G. , et al. An alternative method for PAI-1 promoter polymorphism (4G/5G) typing . Thromb Haemost 1997; 77(3): 605—6.

12.

Jern C. , Ladenvall P. , Wall U. , Jern S. Gene polymorphism of t-PA is associated with forearm vascular release rate of t-PA. Arterioscler . Thromb Vasc Biol 1999 ; 19(2): 454—9.

13.

van der Bom JG , de Knjiff P. , Haverkate F. , Bots ML , Meijer P. , de Jong PT , et al. Tissue plasminogen activator and risk of myocardial infarction. The Rotterdam Study . Circulation 1997; 95(12): 2623—7.

14.

Hirschhorn JN , Lohmueller K. , Byrne E. , Hirschhorn K. A comprehensive review of genetic association studies . Genet Med 2002; 4(2): 45—61.

15.

van den Eijnden-Schrauwen Y. , Lakenberg N. , Emeis JJ , de Knijff P. Alu-repeat polymorphism in the tissue type plasminogen activator gene does not affect basal endothelial tPA synthesis . Thromb Haemost 1995; 74(4): 1202 .

16.

Chandler WL , Levy WC , Stratton JR The circulatory regulation of TPA and UPA secretion, clearance, and inhibition during exercise and during the infusion of isoproterenol and phenylephrine . Circulation 1995; 92(10): 2984—94.

17.

Chandler WL , Alessi MC , Aillaud MF , Henderson P. , Vague P. , Juhan-Vague I. Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-l) complex: relationship to elevated TPA antigen in patients with high PAI-1 activity levels . Circulation 1997; 96(3): 761—8.

18.

Ladenvall P. , Nilsson S. , Jood K. , Rosengren A. , Blomstrand C. , Jern C. Genetic variation at the human tissue-type plasminogen activator (tPA) locus: haplotypes and analysis of association to plasma levels of tPA . Eur J Hum Genet 2003 ; 11(8): 603—10.